Shichun Li

561 citations
18 papers · 444 indexed · h-index 11
Topics
Neuroinflammation and Neurodegeneration Mechanisms (6 papers)Immune cells in cancer (4 papers)Neurological Disease Mechanisms and Treatments (3 papers)

In The Last Decade

Shichun Li

18 papers receiving 442 citations

Peers

Shichun Li
Comparison fields: 5 of 68
  • Molecular Biology 258
  • Neurology 96
  • Endocrinology, Diabetes and Metabolism 92
  • Cancer Research 70
  • Complementary and alternative medicine 58
Replace Pengchao Du with:
Pengchao Du China
Lifa Huang China
Yan-ting Gu China
Qiang Xue China
Jiaqi Lu China
Chulei Deng China
Jiayu Tang China
Shichun Li relative to Pengchao Du China Pengchao Du's profile →
Citations per field
00.5×4.4×
Pengchao Du · 1×
Citations per year

Countries citing papers authored by Shichun Li

Since Specialization
Citations

This map shows the geographic impact of Shichun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shichun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shichun Li more than expected).

Fields of papers citing papers by Shichun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shichun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shichun Li. The network helps show where Shichun Li may publish in the future.

Co-authorship network of co-authors of Shichun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shichun Li. A scholar is included among the top collaborators of Shichun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shichun Li. Shichun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 4
2 2
3 2
4 16
5 5
6 13
7 23
8 10
9 2
10 3
11 15
12 100
13 35
14 11
15 13
16 34
17
Grb10: A new substrate of the insulin-like growth factor I receptor.
68
18 88

About Shichun Li

Shichun Li is a scholar working on Neurology, Geriatrics and Gerontology and Developmental Neuroscience, having authored 18 papers that have together received 444 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Immune cells in cancer (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Neurology (96 citations), Complementary and alternative medicine (58 citations) and Geriatrics and Gerontology (26 citations). Shichun Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Renato Baserga, Andres Ferbér, Masahiko Miura, Zunji Ke, Man Li, Zhifei Wang, Benjamin Margolis, Barbara Valentinis, Andrea Morrione and Rui Ding. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026